Vitamin E in the prevention of ischemic heart disease

Pharmacological Reports

Volumn 58, Issue 2, 2006, Pages 179-187

  Chattopadhyay, Aindrila ^a   Bandyopadhyay, Debashis ^b  

^a VIDYASAGAR COLLEGE   (India)

^b VISVA BHARATI UNIVERSITY   (India)

Author keywords

Ischemic heart disease; Oxidative stress; Reactive oxygen species; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; REACTIVE OXYGEN METABOLITE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIET; DRUG ABSORPTION; DRUG STRUCTURE; DRUG USE; ECONOMIC ASPECT; EXERCISE; FOOD INTAKE; FRUIT; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HEART FUNCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; REVIEW; STRESS; VEGETABLE;

EID: 33646783327     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Bendich A, Gabriel E, Machlin LJ: Dietary vitamin E requirement for optimum immune responses in the rat. J Nutr, 1986, 116, 675-681.
2. Bendich A, Machlin LJ: Safety of oral intake of vitamin E. Am J Clin Nutr, 1988, 48, 612-619.
3. Bendich A, Machlin LJ: The safety of oral intake of vitamin E: data from clinical studies from 1986 to 1991. In: Vitamin E in Health and Disease. Ed. Packer L, Fuchs J, Marcel Dekker Inc, New York, 1993, 411-416.
4. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA: Association between cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med, 1998, 338, 1650-1656.
5. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A et al.: Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomized placebo-controlled trial. Lancet, 2000, 356, 1213-1218.
6. Bolli R: Mechanisms of myocardial stunning. Circulation, 1990, 82, 723-738.
7. Braunwald E, Kloner R A: Myocardial reperfusion: a double edged-sword? J Clin Invest, 1985, 76, 1713-1719.
8. Burton GW, Joyce A, Ingold KU: Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membrane? Arch Biochem Biophys, 1983, 221, 281-290.
9. Cachia O, El Benna J, Pedruzzi E, Descomps B, Gougerot-Pocidalo M-A, Leger CL: Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of Pruphox membrane translocation and phosphorylation. J Biol Chem, 1998, 273, 32801-32805.
10. Chen Y, Davis-Gorman G, Watson RR, McDonagh PF: Vitamin E attenuates myocardial ischemia-reperfusion injury in murine AIDS. Cardiovasc Toxicol, 2002, 2, 119-127.
11. Das N, Das Chowdhury T, Chattopadhyay A, Datta AG: Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol, 2004, 56, 85-96.
12. Diplock AT, Machilin LJ, Packer L, Pryor WA (Ed.): Vitamin E: biochemistry and health implications. New York Academy of Sciences, New York, 1989.
13. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH: Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med, 2004, 164, 1552-1556.
14. Engelen W, Keenoy BM, Vertomen J, De Leeuw I: Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type I diabetes. Am J Clin Nutr, 2000, 72, 1142-1149.
15. Frei B (Ed.): Natural antioxidants in human health and disease. San Diego, CA: Academic Press, 1994.
16. Gey KF, Puska P, Jordan P, Moser UK: Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin, Nutr, 1991, 53, 326S-334S.
17. Hansen PR: Role of neutrophils in myocardial ischemia and reperfusion. Circulation, 1995, 91, 1872-1885.
18. Heinecke JW: Clinical trials of vitamin E in the coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis? Curr Atheroscler Rep. 2003, 5, 83-87.
19. Infante JP: A fuction for the vitamin E metabolite α-tocopherol quinine as an essential enzyme cofactor for the mitochondrial fatty acid desaturases. FEBS Lett, 1999, 446, 1-5.
20. Jailal I, Grundy SM: Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low-density lipoproteins. J Lipid Res, 1992, 33, 899-906.
21. Jialal I, Fuller CJ, Huet BA: The effect of alpha-tocopherol supplementation on LDL oxidation. A dose response study. Atheroscler Thromb Vasc Biol, 1995, 15, 190-198.
22. Jialal I, Traber M, Devaraj S: Is there a vitamin E paradox? Curr Opin Lipidol, 2001, 12, 49-53.
23. Kappus H, Diplock AT: Tolerance and safety of vitamin E: a toxicological position report. Free Radic Biol Med, 1992, 13, 55-74.
24. Kim JM, White RH: Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol, 1996, 77, 545-546.
25. Koren G, Weiss AT, Hasin Y, Appelbaum D, Webber S, Rozenman Y, Lotan C: Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med, 1985, 313, 1384-1389.
26. Ku DD: Coronary vascular reactivity after acute myocardial ischemia. Science, 1982, 218, 576-578.
27. Lefer DJ, Nakanishi K, Vinten-Johansen J, Ma X-L, Lefer AM: Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am J Physiol, 1992, 263, H850-H855.
28. Lubin B, Machilin LJ (Ed.): Vitamin E: biochemical, hematological, and clinical aspects. New York Academy of Sciences, New York, 1982.
29. Lucchesi BR: Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol, 1990, 52, 561-576.
30. Ma X-L, Weyrich AS, Lefer DJ, Lefer AM: Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res, 1993, 72, 403-412.
31. Machlin LJ (Ed.): Vitamin E: a comprehensive treatise. Marcel Dekker Inc., New York, 1980.
32. Marchioli R: GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet, 1999, 354, 447-455.
33. McCord JM: Free radicals and myocardial ischemia: overview and outlook. Free Radic Biol Med, 1988, 4, 9-14.
34. McQueen MJ, Lonn E, Gerstein HC, Bosch J, Yusuf S: The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences. Scand J Clin Lab Invest Suppl, 2005, 240, 143-156.
35. Meydani M: Vitamin E modulation of cardiovascular disease. Ann NY Acad Sci, 2004, 1031, 271-279.
36. Meydani SN, Meydani M, Blumberg JB, Leka LS, Pedrosa M, Diamond R, Schaefer EJ: Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am J Clin Nutr, 1998, 68, 311-318.
37. Meyer F, Bairati I, Dagenais GR: Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can J Cardiol, 1996, 12, 930-934.
38. Moens AL, Claeys MJ, Timmermans JP Vrints CJ: Myocardial ischemia/ reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol, 2005, 100, 179-190.
39. Morel DW, dela Liera-Moyaa M, Friday KE: Treatment of cholesterol-fed rabbits with vitamin E and C lipoprotein oxidation but not development of atherosclerosis. J. Nutr, 1994, 124, 2123-2130.
40. Morris MC, Beckett LA, Scherr PA, Hebert LE, Bennett DA, Field TA, Evans DA: Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord, 1998, 12, 121-126.
41. National Hospital Ambulatory Medical Care Survey - 1996 (CDC/NCHS).
42. Packer L, Fuchs J (Ed.): Vitamin E in health and disease. Marcel Decker Inc., New York, 1993.
43. Phase I, National Health and Nutrition Examination Survey III (1988-91).
44. Podhaisky HP, Abate A, Polte T, Oberle S, Schroder H: Aspirin protects endothelial cells from oxidative stress-possible synergism with vitamin E. FEBS Lett, 1997, 41, 349-351.
45. Pryor WA: Free radicals in autoxidation and in aging. Part I. Kinetics of autoxidation of linoleic acid in SDS micelles: calculations of radical concentrations, kinetic chain lengths, and the effects of vitamin E. Part II. The role of radicals in chronic human diseases and in aging. In: Free Radicals in Molecular Biology, Aging and Disease. Ed. Armstrong D, Sohal RS, Cutler RG, Slater TF, NY Raven Press, New York, 1984, 13-41.
46. Pryor WA: The antioxidant nutrient and disease prevention-what do we know and what do we need to find out? Am J Clin Nutr, 1991, 53, Suppl, 391S-393S.
47. Pryor WA: Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med, 2000, 28, 141-164.
48. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A: Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J, 1998, 334, 243-249.
49. Sauberlich HE, Machilin LJ (Ed.): Beyond deficiency: new views on the function and health effects of vitamins. New York Academy of Sciences, New York, 1992.
50. Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu WJ, Suttorp M et al.: Effect of supplemental vitamin E for the prevention of cardiovascular disease. J Gen Intern Med, 2004, 19, 380-389.
51. Simpson PJ, Lucchesi BR: Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med, 1987, 110, 13-27.
52. Stampfer MF, Hennekind CH, Manson JE, Colditz GA, Rosener B: Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med, 1993, 328, 1444-1449.
53. Steiner M, Glantz M, Lekos A: Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr, 1995, 62, Suppl, 1381S-1384S.
54. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP III, Herderick EE, Cornhill JF: Prevalence and extent of atherosclerosis in adolescents and young adults. J Am Med Assoc, 1999, 281, 727-735.
55. Tarr M, Valenzeno DP: Reactive-oxygen induced modification cardiac electrophysiology: a comparison of the effects of Rose Bengal and other reactive oxygen generators. In: Oxygen Free Radicals in Tissue Damage. Ed. Tarr M, Samson F, Brinkhauser, Boston, 1993, 267-284.
56. Tasinato A, Boscoboinik D, Bartoli G-M, Maroni P, Azzi A: α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA, 1995, 92, 12190-12194.
57. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM: Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation, 1990, 82, 1402-1412.
58. Van Benthuysen KM, McMuttry IF, Horwitz LD: Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependant relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest, 1987, 79, 265-274.
59. Verlangieri AJ, Bush MJ: Effects of alpha-tocopherol supplementation on experimentally induced primary atherosclerosis. J Am Coll Nutr, 1992, 11, 131-138.
60. Weiss JN, Goldhaber JI, Sen J: Oxygen free radicals in the pathophysiology of myocardial ischemia/reperfusion. In: Oxygen Free Radicals in Tissue Damage. Ed. Tarr M, Samson F, Brinkhauser, Boston, 1993, 267-284.
61. Werns SW, Lucchesi BR: Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury. Cardiovasc Drugs Ther, 1989, 2, 761-769.
62. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenias G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000, 342, 145-153.
63. Yusuf S: From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis. Am J Cardiol, 2002, 89, 18A-25A.